Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib vs placebo in advanced GIST after imatinib and sunitinib
CTR20131685Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of regorafenib in gastrointestinal stromal tumor (GIST), sponsored by Bayer. Started Apr 2014; status: completed.
02
Drugs
regorafenib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on CTR20131685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131685.